The Role of IEEG in the Localization of EZ and Its Relationship With Prognosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The mechanism of epilepsy pathogenesis is complex and not fully defined, and about 20-30% of patients with seizures that cannot be completely controlled by drugs become drug-resistant epilepsy. For focal drug-resistant epilepsy, surgical removal of the epileptogenic zone can control seizures, but the overall seizure-free rate in the long term after surgery is 60-70%, and the results are still not satisfactory. Accurate assessment of the location and extent of the epileptogenic zone and its adequate excision are prerequisites for the success or failure of surgery. Intracranial EEG (iEEG) has been shown to be the most accurate method for determining the location and boundaries of the epileptogenic zone. It can selectively record the local cortical electrical activity through intracranial electrodes and achieve high temporal resolution for long-range recording, reliably reflecting the continuous dynamic changes of EEG during interictal and ictal periods. The in-depth analysis of iEEG can improve the efficacy of epilepsy surgery and provide important information to reveal the pathogenesis of epilepsy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 70
Healthy Volunteers: f
View:

• Complete clinical history;

• IEEG monitoring at least one habitual seizure;

• Follow up for at least 1 year;

• Signed informed consent.

Locations
Other Locations
China
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITING
Hangzhou
Contact Information
Primary
Lingli Hu, Master
hulingli21@163.com
18613040114
Time Frame
Start Date: 2022-07-01
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 120
Treatments
Seizure free group
Not seizure free group
Related Therapeutic Areas
Sponsors
Leads: Second Affiliated Hospital, School of Medicine, Zhejiang University

This content was sourced from clinicaltrials.gov